Below are some of the details of Bortezomib(generic)
Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma.
more vital info on Velcade's generic
